IE
KZIA

Israel Englander’s Kazia Therapeutics KZIA Stock Holding History

Israel Englander’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43M Buy
+101,376
New +$1.23M ﹤0.01% 4087
2015
Q3 		– Sell
-113
Closed -$91K – 3605
2015
Q2 		$91K Buy
+113
New +$128K ﹤0.01% 3185

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Israel Englander's KZIA Position: Q2 2026 in Review

Israel Englander opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 101,376 shares worth $1.43M. The stake represents ﹤0.01% of the portfolio and ranks #4087 among its holdings. This is a return to the name: Israel Englander previously reported a position in KZIA as recently as Q2 2015.

Israel Englander first reported a position in KZIA in Q2 2015 and has held it in 2 quarters since. 36 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Israel Englander held 101,376 shares of Kazia Therapeutics worth $1.43M as of Q2 2026.
  • Kazia Therapeutics was a new Israel Englander position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4087 holding.
  • Israel Englander first reported a position in Kazia Therapeutics in Q2 2015 and has held it in 2 quarters since.
  • 36 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.